Skip to main content


Open Peer Review Reports for: Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3

Back to article

Pre-publication versions of this article are available by contacting

Original Submission
19 Sep 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Nov 2013 Reviewed Reviewer Report - Chris Scarlett
1 Dec 2013 Reviewed Reviewer Report - Adnan Nagrial
2 Jan 2014 Author responded Author comments - Dirk Spitzer
Resubmission - Version 3
2 Jan 2014 Submitted Manuscript version 3
18 Jan 2014 Editorially accepted
21 Jan 2014 Article published 10.1186/1471-2407-14-35

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting

You can find further information about the peer review system here.